Scarring Alopecia
Address Permanent Hair Loss with Targeted Scalp Treatments
Understanding Scarring Alopecia
Scarring alopecia, also known as cicatricial alopecia, refers to a group of rare disorders that destroy hair follicles and replace them with scar tissue. This leads to permanent hair loss. It can affect any gender and may present with redness, scaling, pain, or itching on the scalp.
Scarring alopecia — also called cicatricial alopecia — is a group of conditions in which inflammation destroys the hair follicle and replaces it with scar tissue, resulting in permanent hair loss in the affected areas. Unlike alopecia areata, where follicles are suppressed but intact, scarring alopecia eliminates the follicle's ability to regrow hair entirely.
Treatment Options
Scarring alopecia cannot be managed with over-the-counter products or general hair loss treatments like minoxidil alone. The inflammatory process that destroys follicles requires prescription-strength immunomodulatory or antibiotic therapy guided by accurate subtype diagnosis. Delayed treatment is the primary reason for extensive permanent hair loss in these conditions — every month of unchecked inflammation means more follicles irreversibly scarred.
Treatment Options for Scarring Alopecia
PRP Therapy for Hair Growth
PRP therapy can help preserve the follicles at the edges of scarring patches before they are permanently damaged. Early intervention gives the best chance of slowing the scarring process.
Hair Transplant Consultation
Once scarring alopecia is stabilised, a transplant consultation evaluates whether grafting into the scarred areas is viable. Not all scarring types are suitable, so proper assessment is key.
Mesotherapy for Hair
Mesotherapy nourishes the remaining healthy follicles surrounding the scarred zones. Supporting these follicles keeps them productive and helps prevent the scarring from spreading further.
Ideal Candidates
Patients with early or stable scarring alopecia can benefit from medical and supportive treatments to halt progression and improve scalp condition. Early intervention is critical.
Scarring alopecia is less common than non-scarring hair loss, but its permanent nature makes it among the most consequential diagnoses in hair dermatology. Frontal fibrosing alopecia has increased markedly in prevalence over the past two decades for reasons that remain unclear — environmental triggers including sunscreen chemical filters and fragrances are under investigation. Central centrifugal cicatricial alopecia disproportionately affects women of African descent and is linked to certain hairstyling practices.
Treatment Flow
01
Diagnosis & Scalp Biopsy
Clinical assessment and biopsy are used to confirm the diagnosis and identify the type of scarring alopecia. Your dermatologist performs a thorough scalp examination using dermoscopy to identify perifollicular inflammation, fibrosis, loss of follicular openings, and other diagnostic markers. The distribution pattern is documented and photographed.
02
Medications & Inflammation Control
A combination of steroids, anti-inflammatory agents, and systemic drugs is initiated. Once the subtype is confirmed, we initiate the appropriate systemic medication — hydroxychloroquine for LPP/FFA, or combination antibiotics for neutrophilic forms. Baseline blood tests for liver and kidney function are reviewed before starting systemic therapy.
03
Supportive Scalp Care
Laser, PRP, or topical agents may be added to soothe and support scalp healing. Active treatment involves monthly clinic visits for dermoscopic assessment, intralesional steroid injections to areas of concentrated inflammation, and ongoing systemic medication adjustment. Disease activity is scored at each visit using standardised criteria.
04
Monitoring & Hair Restoration
Once stabilized, hair restoration options like transplants are explored. Once disease activity is suppressed — confirmed by absence of dermoscopic inflammation markers over two to three consecutive visits — systemic medication is tapered slowly.
Results & Recovery
Hair loss progression can be halted in most patients.
Inflammation and discomfort reduce with therapy.
Scalp appearance improves; cosmetic options restore confidence.
Got Questions?We've Got Answers
Find answers to the most common questions about our treatments, procedures, and recovery process. If you can't find what you're looking for, our support team is always here to help.
Unfortunately, once a follicle is destroyed, hair loss is permanent. However, early treatment can stop progression.
Yes, but only after the condition is inactive. A thorough scalp evaluation is needed.
A scalp biopsy is often required to confirm the diagnosis and identify the underlying cause.
Alopecia areata is non-scarring and may allow regrowth. Scarring alopecia leads to permanent follicle destruction.
Yes, especially in traction alopecia, where tight hairstyles pull on follicles and cause long-term damage.
Once a follicle has been destroyed and replaced by scar tissue, it cannot produce hair again — this is what makes scarring alopecia fundamentally different from conditions like alopecia areata. Treatment halts further destruction but does not restore already-scarred follicles. However, follicles at the active margins of disease that are inflamed but not yet fully destroyed can recover with prompt treatment.
Diagnosis combines clinical examination, dermoscopy, and often a scalp biopsy. Dermoscopy reveals characteristic features like perifollicular scaling, loss of follicular ostia, and white patches indicating fibrosis. A 4 mm punch biopsy of the active margin — processed with both horizontal and vertical sections — shows the type of inflammatory infiltrate (lymphocytic, neutrophilic, or mixed) and the extent of follicular destruction.
No, these are fundamentally different conditions. Alopecia areata is an autoimmune condition that suppresses follicles temporarily — the follicles remain intact and can regrow. Scarring alopecia destroys follicles permanently through an inflammatory process that replaces them with fibrous tissue.
Treatment duration varies by subtype and individual response. Some patients achieve lasting remission after 12 to 18 months of treatment and can stop medication entirely with ongoing monitoring. Others require low-dose maintenance therapy to prevent reactivation. Folliculitis decalvans tends to be relapsing-remitting, often needing intermittent antibiotic courses.
Start Your Personalized Skincare Plan
At ClairéDerma, we believe that healthy, radiant skinis the foundation of confidence and well-being. Ledby Dr. Mohna Chauhan, our clinic offers personalized dermatological care tailored to each patient's unique needs. With over a decade ofexperience and more than 3000 successfully treated patients,